Immuno-Oncology Insights is an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the current slate of journals for the industrial and academic and immuno-oncology communities.

Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights places R&D and manufacturing challenges and progress across a wide variety of technology fields in context.

To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.

Nucleic acids received a major boost through the ‘proof of concept’ delivered by the tremendously successful COVID-19 vaccines. As a result, investment is flooding in, driving new applications and opportunities. However, this remains a nascent field, which lacks a dedicated provider of both high-level analysis and in-depth technical data. 

Nucleic Acid Insights is specifically designed to give you the understanding and need-to-know information you require to successfully navigate this rapidly evolving space—your go-to online resource keeping you up to date with all the latest news, trends, issues, and breakthroughs across the nucleic acids area.

Vaccine Insights is a peer-reviewed, open-access journal providing insights into development and manufacture of vaccines. 

The journal brings together leading experts from pharma, biotech, academia, and other key stakeholders to address critical issues and put the latest developments into context. Guided by an expert advisory board, the journal covers the most important advances in vaccine development and manufacture across all disease areas. 

All content is free to view—explore articles, interviews, podcasts and more at Vaccine Insights.